The FDA OKs Pfizer-BioNTech's Booster For People 65+ And At High Risk For Severe COVID

A third shot of the vaccine can be given at least six months after the two-dose regimen, according to the authorization. A booster rollout could begin this week.

The FDA OKs Pfizer-BioNTech's Booster For People 65+ And At High Risk For Severe COVID A third shot of the vaccine can be given at least six months after the two-dose regimen, according to the authorization. A booster rollout could begin this week. Read More You received this message because you're subscribed to Breaking News Alerts emails. This email was sent by National Public Radio, Inc., 1111 North Capitol Street NE, Washington, DC 20002 Unsubscribe  |  Privacy Policy